BML Capital Management, LLC ELEV Holdings History
BML Capital Management, LLC's Elevation Oncology Inc Holding Summary
As of 2025-03-31, BML Capital Management, LLC held 5.89 Mil shares of Elevation Oncology Inc(ELEV), totaling $1.53 Mil. This investment constitutes 1.24% of their stock portfolio, and BML Capital Management, LLC now holds 9.95% of the outstanding Elevation Oncology Inc(ELEV) stock.
The initial trade took place in 2022Q4. And since then BML Capital Management, LLC has made 1 purchases of ELEV, at an average price of $0.57, for a total of 5.93 Mil shares. In addition, there have been 1 sales at an average price of $1.29 for 39,963.00 shares. Based on historical transaction data and ELEV's current price of $0.37, BML Capital Management, LLC's estimated gain on his ELEV holdings is $-1.20 Mil, reflecting a -35.21% gain to date.
BML Capital Management, LLC ELEV ($0.37) Holding Chart
BML Capital Management, LLC ELEV ($0.37) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1